See analyst estimates and all valuation multiples for Small Molecules
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $5.6B | 31.1x | 90.7x | |
| $4.6B | 9.8x | 28.1x | |
| $3.9B | 39.9x | -42.5x | |
| $3.1B | 115.2x | -86.9x | |
| $2.9B | 3.6x | 18.7x | |
| $2.2B | 0.9x | 6.5x | |
| $2.2B | 10.7x | -8.5x | |
| $2.1B | 9.1x | 21.8x | |
| $1.4B | 6.3x | 28.2x | |
| $1.4B | 6.6x | 31.3x | |
| $1.3B | 6.3x | 19.4x | |
| $1.2B | n/a | n/a | |
| $918M | n/a | n/a | |
| $810M | 3.7x | 82.9x | |
| $647M | 5.6x | n/a | |
| $643M | 2.6x | 7.6x | |
| $600M | 7.1x | 19.7x | |
| $505M | 42.2x | -2.8x | |
| $405M | 4.2x | n/a | |
| $256M | 1023.6x | n/a | |
| $248M | 4.3x | -3.6x | |
| $241M | n/a | -18.6x | |
| $229M | 2.2x | -49.3x | |
| $187M | n/a | n/a | |
| $145M | 5.4x | -6.6x | |
| $140M | 5.4x | n/a | |
| $136M | n/a | -5.6x | |
| $127M | 37.6x | n/a | |
| $96.9M | 9.6x | n/a | |
| $84.1M | 9.0x | n/a | |
| $71.6M | n/a | -0.6x | |
| $54.4M | 0.5x | -2.1x | |
| $37.3M | 0.8x | n/a | |
| $27.0M | 0.9x | -0.3x | |
| $8.7M | 3.8x | n/a | |
| -$23.2M | n/a | 0.2x | |
| -$98.3M | n/a | n/a | |
| -$142M | -6.4x | 0.8x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Small Molecules